Allogene Therapeutics ALLO Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $61.98M-27.5% | $85.51M-8.5% | $93.45M+29.4% | $72.2M-60.7% | ||
| $198.52M-8.6% | $217.26M-40.6% | $365.54M-19.7% | $455.42M+60.4% | ||
| $257.75M-15.0% | $303.39M-33.9% | $459.12M-13.2% | $528.82M+12.2% | ||
| $72.84M-15.4% | $86.06M-13.5% | $99.48M-11.8% | $112.84M-8.3% | ||
| $415.91M-24.2% | $548.71M-14.6% | $642.84M-21.8% | $821.58M-21.8% | ||
| $4.27M-20.8% | $5.39M-8.5% | $5.9M-57.5% | $13.89M+35.4% | ||
| $32.51M-8.5% | $35.52M-4.2% | $37.08M-31.0% | $53.73M+12.2% | ||
| $123.36M-2.5% | $126.53M-3.1% | $130.6M-15.6% | $154.7M+23.1% | ||
| 400M+188,579% | 212K+25.4% | 169K-100.0% | 400M+100% | ||
| -$2.01B-10.5% | -$1.82B-16.5% | -$1.56B-26.5% | -$1.23B-38.1% | ||
| $292.54M-30.7% | $422.18M-17.6% | $512.23M-23.2% | $666.88M-27.9% | ||
| $415.91M-24.2% | $548.71M-14.6% | $642.84M-21.8% | $821.58M-21.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Allogene Therapeutics's total assets?
- Allogene Therapeutics (ALLO) holds $396.0M in total assets, down 22.1% year over year.
- How much debt does Allogene Therapeutics have?
- Allogene Therapeutics carries $81.1M in total debt against $278.9M of shareholders' equity, a debt-to-equity ratio of 0.29.
- How much cash does Allogene Therapeutics have?
- Allogene Therapeutics holds $40.6M in cash and equivalents.
- Can Allogene Therapeutics cover its short-term obligations?
- Its current ratio is 9.65 — current assets exceed current liabilities.
- Where does Allogene Therapeutics's balance sheet data come from?
- Every line is extracted from Allogene Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.